HNRNPC and breast carcinoma: Heterogeneous nuclear ribonucleoprotein C (HNRNPC), a key m6A modification “Reader”, has been confirmed to be associated with tumor progression and immune suppression in lung cancer, liver cancer, and breast cancer (Lv et al., 2021; Cai et al., 2022).